Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Perspective Therapeutics Inc CATX

Healthcare Biotechnology
Perspective Therapeutics, Inc. is a radiopharmaceutical development company that is developing advanced treatment applications for cancers throughout the body. The Company has proprietary technology that utilizes the alpha-emitting isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting peptides. It is also developing imaging diagnostics that... see more

Recent & Breaking News (NYSEAM:CATX)

Isoray Announces First Quarter Fiscal 2023 Financial Results and Provides Update to Pending Merger

GlobeNewswire November 10, 2022

Isoray To Announce First Quarter Fiscal 2023 Financial Results on November 10, 2022

GlobeNewswire October 31, 2022

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TALO, ISR, FCRD, SESN

PR Newswire October 28, 2022

STOCKHOLDER ALERT: The M&A Class Action Firm Announces the Investigation of Isoray, Inc. - ISR

PR Newswire October 27, 2022

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Isoray, Inc. Merger

Newsfile October 3, 2022

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OCSL, SESN, ISR

PR Newswire September 30, 2022

ISR Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Isoray, Inc. Is Fair to Shareholders

Business Wire September 29, 2022

Viewpoint Molecular Targeting Announces Transformational Merger

Accesswire September 29, 2022

Isoray Announces Transformational Merger and Fourth Quarter and Full-Year Fiscal Year End 2022 Financial Results

GlobeNewswire September 28, 2022

Isoray To Announce Fourth Quarter and Fiscal Year End 2022 Financial Results on September 28, 2022

GlobeNewswire September 21, 2022

Isoray's Cesium-131 Featured in Presentations at American Brachytherapy Society's Annual Conference

GlobeNewswire June 21, 2022

Isoray To Host Lunch Symposium At American Brachytherapy Society's Annual Conference

GlobeNewswire June 15, 2022

Isoray Announces Record Third Quarter Fiscal 2022 Financial Results

GlobeNewswire May 10, 2022

Isoray To Announce Third Quarter Fiscal 2022 Financial Results on May 10, 2022

GlobeNewswire April 29, 2022

Isoray to Participate in the Oppenheimer 32nd Annual Healthcare Conference

GlobeNewswire March 10, 2022

Study Finds Excellent Outcomes for Intermediate Risk Prostate Cancer Patients Treated with Isoray's Cesium-131

GlobeNewswire March 2, 2022

Isoray Announces Second Quarter Fiscal 2022 Financial Results

GlobeNewswire February 8, 2022

Isoray To Announce Second Quarter Fiscal 2022 Financial Results on February 8, 2022

GlobeNewswire January 26, 2022

Isoray Announces First Quarter Fiscal 2022 Financial Results

GlobeNewswire November 10, 2021

Isoray To Announce First Quarter Fiscal 2022 Financial Results on November 10, 2021

GlobeNewswire October 29, 2021